Authors: de Weerdt, O van de Donk, NWCJ Veth, G Bloem, AC Hagenbeek, A Lokhorst, HM

Citation: O. De Weerdt et al., Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma, NETH J MED, 59(2), 2001, pp. 50-56

Authors: Eisterer, W Bechter, O Hilbe, W van Driel, M Lockhorst, HM Thaler, J Bloem, AC Gunthert, U Stauder, R

Citation: W. Eisterer et al., CD44 isoforms are differentially regulated in plasma cell dyscrasias and CD44v9 represents a new independent prognostic parameter in multiple myeloma, LEUK RES, 25(12), 2001, pp. 1051-1057

Authors: van der Griend, R Verdonck, LF Petersen, EJ Veenhuizen, P Bloem, AC Lokhorst, HM

Citation: R. Van Der Griend et al., Donor leukocyte infusions inducing remissions repeatedly in a patient withrecurrent multiple myeloma after allogeneic bone marrow transplantation, BONE MAR TR, 23(2), 1999, pp. 195-197

Authors: Roovers, DJ van Vliet, M Bloem, AC Lokhorst, HM

Citation: Dj. Roovers et al., Idarubicin overcomes P-glycoprotein-related multidrug resistance: comparison with doxorubicin and daunorubicin in human multiple myeloma cell lines, LEUK RES, 23(6), 1999, pp. 539-548